RECRUITING

The Reducing Risk Study

Talk to us

Conditions

InsomniaDelayed Sleep Phase

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The present study will test an innovative mobile health adaptation of a behavioral intervention that improves sleep and mental health concerns among adolescents.

Official Title

Reducing Risk: A Comprehensive mHealth Sleep Health Intervention for Adolescents at Risk for Depression and Anxiety Disorders

Quick Facts

Study Start:2020-09-01
Study Completion:2024-08-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03665337

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:12 Years to 18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * any current psychiatric illness
  2. * currently use of medications or herbs with known effects on sleep
  3. * hospitalization for substance use or suicide within the past 12 months
  4. * known sleep apnea
  5. * unstable major medical conditions
  6. * current psychotherapy for depression, anxiety or sleep health deficits

Contacts and Locations

Study Contact

Lauren Asarnow, PhD
CONTACT
(415) 476-7439
Lauren.Asarnow@ucsf.edu

Principal Investigator

Lauren Asarnow, PhD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

University of California, San Francisco
San Francisco, California, 94143
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Lauren Asarnow, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-09-01
Study Completion Date2024-08-01

Study Record Updates

Study Start Date2020-09-01
Study Completion Date2024-08-01

Terms related to this study

Additional Relevant MeSH Terms

  • Insomnia
  • Delayed Sleep Phase